@ARTICLE{
author={Hanna Nasser H|,Kaiser Rolf|,Sullivan Richard N|,Aren Osvaldo Rudy|,Ahn Myung-Ju|,Tiangco Beatrice|,Voccia Isabelle|,von Pawel Joachim|,Kovcin Vladimir N|,Agulnik Jason|,Gaschler-Markefski Birgit|,Barrueco Jose|,Sikken Patricia|,Schloss Charles|,Kim Joo-Hang|},
year={2016},
title={Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial},
journal={LUNG CANCER},
volume={102},
number={},
pages={65-73},
document_type={Article},
}